Ching-Ting Wei

Dr. Ching-Ting Wei


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CWChing-Ting Wei
Ching-Ting Wei
YWYu-Wen Wang
Yu-Wen Wang
YWYu-Chiuan Wu
Yu-Chiuan Wu
LLLi-wei Lin
Li-wei Lin
Chia-Chi ChenChia-Chi Chen
Chia-Chi Chen
SKShyh Ming Kuo
Shyh Ming Kuo
Airborne fine particulate matter (PM2.5) is a severe problem and is associated with health issues including liver diseases. Workers performing manual labor tend to be alcohol consumers during work, where they are also exposed to PM2.5. Long-term PM2.5 exposure can increase oxidative stress, leading to inflammation. Whether long-term exposure to air pollution and alcohol synergistically increases liver fibrosis risk warrants investigation. Oleanolic acid (OA)—a triterpenoid—has antioxidant and anti-inflammatory activities, but its low water solubility and cytotoxicity impair its potential applications. In this study, we fabricated liposomal OA nanoparticles (Lipo-OAs); then, we evaluated the anti-inflammatory effect on exposed cells and the ameliorative effect of Lipo-OAs on PM2.5 and alcohol-induced liver fibrosis in mice. The half maximal inhibitory concentration of PM2.5 for hepatic stellate cells was 900 μg/mL; at a concentration of ≥600 μg/mL, PM2.5 significantly increased interleukin-6 and tumor necrosis factor-α production. OA encapsulation in Lipo-OAs, 353 ± 140 nm in diameter with 79% encapsulation efficiency, significantly reduced OA cytotoxicity. Lipo-OAs treatment significantly reduced alanine aminotransferase, aspartate aminotransferase, and γ-glutamyltransferase levels; histologically, it alleviated steatosis and improved Ishak’s modified HAI score. In conclusion, Lipo-OAs have potential anti-inflammatory and reparative effects for PM2.5 and alcohol-induced liver injury treatment.

TLThung Lip Lee
Thung Lip Lee
CHChin-Feng Hsuan
Chin-Feng Hsuan
CWCheng-Ching Wu
Cheng-Ching Wu
WHWei-Chin Hung
Wei-Chin Hung
ITI-Ting Tsai
I-Ting Tsai
YLYung-Chuan Lu
Yung-Chuan Lu
Objectives: Increased triglyceride glucose (TyG) index appears to be linked to carotid and coronary atherosclerosis and calcifications and possesses an elevated future risk of developing cardiovascular disease. Corrected QT (QTc) interval prolongation is associated with ventricular arrhythmias and sudden cardiac death, and a high prevalence of prolonged QTc interval was previously reported in blue-collar workers. The purpose of this study was to find the possible causal inter-relationship between TyG index and QTc interval in a large population of Chinese male steelworkers. Methods: A total of 3189 male workers from two steel plants were enrolled. They responded to a cross-sectional questionnaire on basic attributes and lifestyle, including sleep patterns. All workers in the two plants underwent periodic health checkups, including twelve-lead electrocardiography. Structural equation modeling (SEM) was used to assess the direct and indirect effects of TyG index on QTc interval. Results: With increasing TyG index tertile, the male steelworkers had an increased QTc interval. Applying multivariate analysis, TyG index was associated independently with the odds of QTc prolongation (adjusted odds ratio = 2.73, 95% confidence interval = 1.39–5.24, p = 0.004). SEM revealed that TyG index, hypertension, obesity, lifestyle, white blood cell (WBC) count, and liver function had statistically significant direct effects on QTc interval. Furthermore, TyG index also had an indirect effect on QTc interval through hypertension, obesity, WBC count, and liver function. Moreover, lifestyle had an indirect effect on QTc interval through TyG index. The final model explained 14% of the variability in QTc interval. Conclusions: An increased TyG index was associated with QTc interval prolongation in this study, and SEM delineated possible causal pathways and inter-relationships of the risk factors contributing to the occurrence of QTc prolongation among Chinese male steelworkers.

15 January 2014 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
CWChing-Ting Wei
Ching-Ting Wei
YCYaw-Sen Chen
Yaw-Sen Chen
Cheuk-Kwan SunCheuk-Kwan Sun
Cheuk-Kwan Sun
KHKun-Chou Hsieh
Kun-Chou Hsieh
Introduction: A superior lumbar hernia, which is also known as a Grynfeltt hernia, is a rare abdominal wall defect that can be primary or secondary to trauma or orthopedic surgery. The anatomic location of a lumbar hernia makes diagnosis and repair challenging. We successfully repaired a lumbar hernia using a single-incision laparoscopic total extraperitoneal approach. To the best of our knowledge, this is the first report of the use of this surgical technique in the treatment of a primary Grynfeltt hernia. Case presentation: A 76-year-old Taiwanese man presented to our hospital with a left lower bulging mass noted for over three months. Abdominal computed tomography revealed a left Grynfeltt hernia. We performed a single-incision laparoscopic total extraperitoneal repair. Our patient was discharged uneventfully on the fourth day after the operation. There was no evidence of recurrence after six months of follow-up. Conclusion: A laparoscopic total extraperitoneal repair for a lumbar hernia provides an excellent operative view and minimal invasiveness. The single-incision technique also provides better cosmetic outcomes. Our experience suggests that the single-incision laparoscopic total extraperitoneal approach may be a feasible and safe alterative to conventional approaches in lumbar hernia repair.

1 January 2024 in Breast Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
Chia-Chi ChenChia-Chi Chen
Chia-Chi Chen
WTWei-Hua Tang
Wei-Hua Tang
CWCheng-Ching Wu
Cheng-Ching Wu
TLThung-Lip Lee
Thung-Lip Lee
ITI-Ting Tsai
I-Ting Tsai
CWChing-Ting Wei
Ching-Ting Wei
Objective: Breast cancer is the second most common malignancy globally and a leading cause of cancer death in women. Analysis of factors related to disease-free survival (DFS) has improved understanding of the disease and characteristics related to recurrence. The aim of this study was to investigate the predictors of DFS in patients with breast cancer to enable the identification of patients at high risk who may benefit from prevention interventions. Methods: We retrospectively analyzed 559 women with breast cancer who underwent treatment between 2004 and 2022. The study endpoint was DFS. Recurrence was defined as local recurrence, regional recurrence, distant metastases, contralateral breast cancer, other second primary cancer, and death. Baseline tumor-related characteristics, treatment-related characteristics, sociodemographic and biochemical data were analyzed using Cox proportional hazards analysis. Results: The median DFS was 45 months (range, 2 to 225 months). Breast cancer recurred in 86 patients (15.4%), of whom 10 had local recurrence, 10 had regional recurrence, 17 had contralateral breast cancer, 29 had distant metastases, 10 had second primary cancer, and 10 patients died. Multivariate forward stepwise Cox regression analysis showed that AJCC stage III, Ki67 ≥ 14%, albumin, platelet, and red cell distribution width-standard deviation (RDW-SD) were predictors of worse DFS. In addition, the effects of albumin, platelet, and RDW-SD on disease recurrence were confirmed by structural equation model (SEM) analysis. Conclusion: In addition to the traditional predictors of worse DFS such as AJCC stage III and Ki67 ≥ 14%, lower pretreatment circulating albumin, higher pretreatment circulating platelet count and RDW-SD could significantly predict worse DFS in this study, and SEM delineated possible causal pathways and inter-relationships of albumin, platelet, and RDW-SD contributing to the disease recurrence among Chinese women with breast cancer.

18 February 2023 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
CCChi-Chang Chang
Chi-Chang Chang
CHChia-Chang Hsu
Chia-Chang Hsu
TYTeng-Hung Yu
Teng-Hung Yu
WHWei-Chin Hung
Wei-Chin Hung
SKShyh-Ming Kuo
Shyh-Ming Kuo
CWChing-Ting Wei
Ching-Ting Wei
Liver-type fatty acid-binding protein (L-FABP) is widely expressed in hepatocytes and plays a role in lipid metabolism. It has been demonstrated to be overexpressed in different types of cancer; however, few studies have investigated the association between L-FABP and breast cancer. The aim of this study was to assess the association between plasma concentrations of L-FABP in breast cancer patients and the expression of L-FABP in breast cancer tissue. A total of 196 patients with breast cancer and 57 age-matched control subjects were studied. Plasma L-FABP concentrations were measured using ELISA in both groups. The expression of L-FABP in breast cancer tissue was examined using immunohistochemistry. The patients had higher plasma L-FABP levels than the controls (7.6 ng/mL (interquartile range 5.2–12.1) vs. 6.3 ng/mL (interquartile range 5.3–8.5), p = 0.008). Multiple logistic regression analysis showed an independent association between L-FABP and breast cancer, even after adjusting for known biomarkers. Moreover, the rates of pathologic stage T2+T3+T4, clinical stage III, positive HER-2 receptor status, and negative estrogen receptor status were significantly higher in the patients with an L-FABP level greater than the median. Furthermore, the L-FABP level gradually increased with the increasing stage. In addition, L-FABP was detected in the cytoplasm, nuclear, or both cytoplasm and nuclear of all breast cancer tissue examined, not in the normal tissue. Plasma L-FABP levels were significantly higher in the patients with breast cancer than in the controls. In addition, L-FABP was expressed in breast cancer tissue, which suggests that L-FABP may be involved in the pathogenesis of breast cancer.

21 April 2023 in Research Square
Verified
Preprint
Open access
PDF file
CCChia-Chi Chen
Chia-Chi Chen
WTWei-Hua Tang
Wei-Hua Tang
CWCheng-Ching Wu
Cheng-Ching Wu
TLThung-Lip Lee
Thung-Lip Lee
ITI-Ting Tsai
I-Ting Tsai
CWChing-Ting Wei
Ching-Ting Wei
BackgroundBreast cancer is the second most common malignancy globally and a leading cause of cancer death in women. Analysis of factors related to disease-free survival (DFS) has improved understanding of the disease and characteristics related to recurrence. The aim of this study was to investigate the predictors of DFS in patients with breast cancer to enable the identification of patients at high risk who may benefit from prevention interventions.MethodsWe retrospectively analyzed 559 women with breast cancer who underwent treatment between 2004 and 2022. The study endpoint was DFS (including local recurrence, regional recurrence, secondary breast cancer, or death from any cause). Baseline tumor-related characteristics, treatment-related characteristics, sociodemographic and biochemical data were analyzed using Cox proportional hazards analysis and receiving operating characteristic curves. The median DFS was 45 months (range, 2 to 225 months).ResultsBreast cancer recurred in 86 patients (15.4%). Regression analysis showed that age, body mass index, surgery type, T3-T4 clinical tumor stage, tumor grade 3, American Joint Committee on Cancer (AJCC) stage III, Ki67 ≥ 14%, estrogen receptor-negative, progesterone receptor-negative, chemotherapy, carcinoembryonic antigen, CA153, red cell distribution width (RDW)-standard deviation (SD), aspartate aminotransferase, estimated glomerular filtration rate, albumin, hemoglobin, RDW-coefficient of variation, and platelet, white blood cell, neutrophil and monocyte count were associated with DFS. Multivariate Cox regression analysis showed that AJCC stage III, Ki67 ≥ 14%, albumin, platelet, and RDW-SD were independently associated with DFS. Furthermore, Kaplan-Meier analysis showed that albumin ≤ 4.1 g/dl, platelet ≥ 253 10^3/µl, RDW-SD ≥ 44 fL were significantly reduced DFS in patients with breast cancer.ConclusionsIn addition to the traditional prognostic factors such as AJCC stage III and Ki67 ≥ 14%, preoperative a cutoff albumin value of ≤ 4.1 g/dl, a cutoff platelet value of ≥ 253 10^3/µl, and a cutoff RDW-SD value of ≥ 44 fL could significantly predict DFS in patients with breast cancer.